Latest stories on AEMD
AETHLON MEDICAL INC (AEMD) files 8-K
SEC 8-K50 · neutralgeneral
AETHLON MEDICAL INC (AEMD) files 8-K
SEC 8-K50 · neutralgeneral
H.C. Wainwright reiterates Aethlon Medical stock rating at Neutral
Investing.com Analyst Ratings50 · neutralanalyst
Aethlon outlines plan to complete oncology trial follow-up by end of 2026 while targeting 12 months of runway
Seeking Alpha56 · neutralgeneral
Aethlon Medical, Inc. (AEMD) Q1 2027 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
AETHLON MEDICAL INC (AEMD) files 8-K
SEC 8-K50 · neutralgeneral
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
PR Newswire50 · neutralearnings
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
PR Newswire50 · neutralearnings
Aethlon Medical Announces Reverse Stock Split Implementation
TipRanks25 · bearishgeneral
AETHLON MEDICAL INC (AEMD) files 8-K
SEC 8-K50 · neutralgeneral
Aethlon Medical Announces July 2026 Financing Offering
TipRanks28 · bearishgeneral
AETHLON MEDICAL INC (AEMD) files 8-K
SEC 8-K50 · neutralgeneral
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
PR Newswire28 · bearishgeneral
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak | AEMD Stock News
StockTitan58 · neutralproduct/pr
Aethlon Earnings Call: Progress, Cuts, and Cash Strain
TipRanks42 · neutralearnings
Aethlon outlines Cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances
Seeking Alpha58 · neutralproduct/pr
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Aethlon Medical Reports Fiscal 2026 Results, Clinical Progress
TipRanks55 · neutralearnings
Aethlon (AEMD) Q4 2026 Earnings Transcript
The Motley Fool50 · neutralearnings
Aethlon Medical reports FY results
Seeking Alpha53 · neutralearnings
AETHLON MEDICAL INC (AEMD) files 8-K
SEC 8-K50 · neutralgeneral